DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 1Dr.Reddy's Laboratories Limited
02 1Apothecon Pharmaceuticals Pvt Ltd
03 1Chongqing Huapont Pharmaceutical Co., Ltd
04 1Emcure Pharmaceuticals Limited
05 1Heraeus Precious Metals GmbH & Co. KG
06 1Hetero Labs Limited
07 1MSN LABORATORIES PRIVATE LIMITED
08 1NATCO PHARMA LIMITED
09 1Olon SpA
10 1SHILPA PHARMA LIFESCIENCES LIMITED
11 1Sionc Pharmaceutical Private Limited
12 1VALARY LAB LIMITED
01 2BENDAMUSTINE HYDROCHLORIDE MONOHYDRATE
02 1Bendamustine
03 6Bendamustine Hydrochloride
04 1Bendamustine Hydrochloride Monohydrate
05 1Bendamustine hydrochloride
06 1bendamustine hydrochloride
01 1China
02 1Germany
03 8India
04 1Italy
05 1Blank
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
NDC Package Code : 55111-938
Start Marketing Date : 2011-03-30
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
BENDAMUSTINE HYDROCHLORIDE MONOHYDRATE
NDC Package Code : 76339-156
Start Marketing Date : 2019-09-07
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (9.999kg/9.999kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 48943-0019
Start Marketing Date : 2009-03-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 14593-834
Start Marketing Date : 2023-09-21
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (5kg/5kg)
Marketing Category : BULK INGREDIENT
BENDAMUSTINE HYDROCHLORIDE MONOHYDRATE
NDC Package Code : 54875-0011
Start Marketing Date : 2013-05-02
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 68554-0050
Start Marketing Date : 2012-12-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 54893-0003
Start Marketing Date : 2011-09-21
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 70225-1101
Start Marketing Date : 2015-11-19
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 17337-0306
Start Marketing Date : 2018-11-07
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
BENDAMUSTINE HYDROCHLORIDE MONOHYDRATE
NDC Package Code : 76055-0023
Start Marketing Date : 2019-12-31
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Bendamustine Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Bendamustine Hydrochloride, including repackagers and relabelers. The FDA regulates Bendamustine Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Bendamustine Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Bendamustine Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Bendamustine Hydrochloride supplier is an individual or a company that provides Bendamustine Hydrochloride active pharmaceutical ingredient (API) or Bendamustine Hydrochloride finished formulations upon request. The Bendamustine Hydrochloride suppliers may include Bendamustine Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Bendamustine Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Bendamustine Hydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Bendamustine Hydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Bendamustine Hydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Bendamustine Hydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Bendamustine Hydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Bendamustine Hydrochloride suppliers with NDC on PharmaCompass.
We have 11 companies offering Bendamustine Hydrochloride
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
